BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19548859)

  • 1. Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.
    Cook AM; Whitlow J; Hatton J; Young B
    Expert Opin Drug Saf; 2009 Jul; 8(4):411-9. PubMed ID: 19548859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.
    Sullivan PG; Thompson MB; Scheff SW
    Exp Neurol; 1999 Nov; 160(1):226-34. PubMed ID: 10630207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury.
    Lulic D; Burns J; Bae EC; van Loveren H; Borlongan CV
    Neurosurgery; 2011 May; 68(5):1172-85; discussion 1185-6. PubMed ID: 21307793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury.
    Sullivan PG; Thompson M; Scheff SW
    Exp Neurol; 2000 Feb; 161(2):631-7. PubMed ID: 10686082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
    Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study.
    Mazzeo AT; Alves OL; Gilman CB; Hayes RL; Tolias C; Niki Kunene K; Ross Bullock M
    Acta Neurochir (Wien); 2008 Oct; 150(10):1019-31; discussion 1031. PubMed ID: 18781275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone in the clinical treatment of acute traumatic brain injury.
    Stein DG; Wright DW
    Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI.
    Mazzeo AT; Beat A; Singh A; Bullock MR
    Exp Neurol; 2009 Aug; 218(2):363-70. PubMed ID: 19481077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A disposition following acute traumatic brain injury.
    Empey PE; McNamara PJ; Young B; Rosbolt MB; Hatton J
    J Neurotrauma; 2006 Jan; 23(1):109-16. PubMed ID: 16430377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP.
    Pandya JD; Pauly JR; Sullivan PG
    Exp Neurol; 2009 Aug; 218(2):381-9. PubMed ID: 19477175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats.
    Readnower RD; Pandya JD; McEwen ML; Pauly JR; Springer JE; Sullivan PG
    J Neurotrauma; 2011 Sep; 28(9):1845-53. PubMed ID: 21875332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.
    Mazzeo AT; Brophy GM; Gilman CB; Alves OL; Robles JR; Hayes RL; Povlishock JT; Bullock MR
    J Neurotrauma; 2009 Dec; 26(12):2195-206. PubMed ID: 19621985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.
    Sullivan PG; Sebastian AH; Hall ED
    J Neurotrauma; 2011 Feb; 28(2):311-8. PubMed ID: 21142667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.
    Kulbe JR; Hill RL; Singh IN; Wang JA; Hall ED
    J Neurotrauma; 2017 Apr; 34(7):1291-1301. PubMed ID: 27596283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature.
    Schouten JW
    Curr Opin Crit Care; 2007 Apr; 13(2):134-42. PubMed ID: 17327733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury.
    Signoretti S; Marmarou A; Tavazzi B; Dunbar J; Amorini AM; Lazzarino G; Vagnozzi R
    J Neurotrauma; 2004 Sep; 21(9):1154-67. PubMed ID: 15453986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application.
    Osman MM; Lulic D; Glover L; Stahl CE; Lau T; van Loveren H; Borlongan CV
    Neuropeptides; 2011 Dec; 45(6):359-68. PubMed ID: 21592568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone.
    Sayeed I; Parvez S; Wali B; Siemen D; Stein DG
    Brain Res; 2009 Mar; 1263():165-73. PubMed ID: 19368823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
    Sayeed I; Stein DG
    Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.